How is eLife measuring up?

In 2012, the open access biomedical journal eLife was launched to challenge the dominance of titles such as Nature, Science and Cell

June 16, 2016
How is eLife measuring up? infographic (16 June 2016)

View high-resolution version


This month, eLife’s backers – the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust – said that they would extend support until 2022 with a £25 million boost.

Four years on, how is eLife doing?

It is now publishing as many papers as Nature, with acceptance rates falling from more than one in four when it was set up to about 15 per cent last year.

Along with many other academic critics, eLife rejects the use of journal impact factors, which measure the average number of citations papers receive. However, the measure remains watched by some researchers hoping for promotion, and on this count, eLife remains behind Nature.

Science declined to give year-by-year breakdowns for acceptance rates and papers published. A spokeswoman said that about 800 papers were published each year, and 6 to 7 per cent of submissions were accepted. Science’s journal impact factor has remained in the low 30s throughout the period.

david.matthews@tesglobal.com

POSTSCRIPT:

Print headline: Taking stock: how is eLife measuring up?

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Register
Please Login or Register to read this article.

Related articles

Sponsored